L1 syndrome

L1 syndrome is a group of X-linked neurological conditions caused by mutations in the L1CAM gene, which encodes the L1 cell adhesion molecule important for nervous system development. L1 syndrome encompasses several previously described conditions that are now recognized as a clinical spectrum, including X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (HSAS), MASA syndrome (Mental retardation, Aphasia, Shuffling gait, Adducted thumbs), X-linked complicated hereditary spastic paraplegia type 1 (SPG1), and X-linked complicated corpus callosum agenesis. The condition primarily affects the central nervous system and musculoskeletal system. Key clinical features include hydrocephalus (often due to aqueductal stenosis), intellectual disability of variable severity, spasticity of the lower limbs, adducted (clasped) thumbs, hypoplasia or agenesis of the corpus callosum, and corticospinal tract hypoplasia. The severity of symptoms can vary considerably, even within the same family. Males are primarily affected, while carrier females are usually asymptomatic or may have very mild features. Hydrocephalus may be detected prenatally or at birth, and can be severe enough to cause macrocephaly. There is no cure for L1 syndrome. Treatment is supportive and symptomatic. Hydrocephalus often requires neurosurgical intervention, typically ventriculoperitoneal shunt placement or endoscopic third ventriculostomy. Physical therapy, occupational therapy, and speech therapy are important for managing spasticity and developmental delays. Orthopedic interventions may be needed for adducted thumbs or lower limb spasticity. Genetic counseling is recommended for affected families. Prognosis varies widely depending on the severity of hydrocephalus and associated brain malformations, ranging from severe neonatal presentations to milder forms with moderate intellectual disability and spastic paraplegia.

Common questions about L1 syndrome